Circulation

MARCH 9, 2025

Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025. Urinary albumin-to-creatinine ratio is an attractive, unifying biomarker of cardiovascular, kidney, and metabolic conditions that may be useful for identifying and monitoring disease trajectory.

Kidney Disease 83

Kidney Disease Biomarkers Heart Failure Risk Factors 83

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP88-AWP88, February 1, 2025. Background:The effect of renal dysfunction on early infarct growth rate (IGR) in anterior circulation large vessel occlusion (ACLVO) stroke is not well studied. mg/dL, p < 0.05) and lower median eGFR (66.2 mL/min/1.73m2, p < 0.05).

Biomarkers 40

Biomarkers Circulation Stroke Strokes 40

DAIC

FEBRUARY 3, 2025

tim.hodson Mon, 02/03/2025 - 12:30 January 29, 2025 Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 Circulation. 2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA). This will be the first 510(k) cleared test of its kind available in the U.S. Arnett DK et al.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP140-ATP140, February 1, 2025. We identify circulating proteomic signatures for ischemic stroke prognosis, and correlate these with clinical data to develop a proteomic profile of 14 markers. AUC range:0.65-0.99).Conclusion:We

Biomarkers 40

Biomarkers Stroke Strokes Technology 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWMP101-AWMP101, February 1, 2025. It remains unclear if the biomarkers used in the trial reliably identified atrial cardiopathy. It remains unclear if the biomarkers used in the trial reliably identified atrial cardiopathy. and Canada. 1.16), PTFV1 (OR per SD, 1.06; 95% CI, 0.98-1.15),

Biomarkers 40

Biomarkers Cardiomyopathy Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A74-A74, February 1, 2025. There is a need for surrogate imaging biomarkers that more strongly associate with functional outcome, to refine prognostication and facilitate development of EVT-adjuvant neuroprotective therapies. a measure of infarct severity). MRI was performed 1248 hours post-EVT.

Biomarkers 40

Biomarkers Outcomes Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP341-ATP341, February 1, 2025. Introduction:Peripheral blood-based biomarker development for neurological diseases such as ischemic stroke has traditionally focused on measuring alterations in leukocyte number and composition.

Biomarkers 40

Biomarkers Stroke Strokes Outcomes 40